Cargando…
43. BUILDING ON GENETICS AND PATHOPHYSIOLOGY OF SCHIZOPHRENIA TO GUIDE DISCOVERY OF NEW TREATMENTS
Overall Abstract: Current treatments for schizophrenia (SCZ) are partially effective in treating positive symptoms, but many patients are refractory to available medications and they are ineffective in the treatment of negative symptoms and cognitive impairment. There is a tremendous need to develop...
Autor principal: | Conn, P Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888738/ http://dx.doi.org/10.1093/schbul/sby014.178 |
Ejemplares similares
-
43.1 GENETIC INSIGHTS LEAD TO DISCOVERY OF SELECTIVE ACTIVATORS OF MGLU1 AND MGLU3 METABOTROPIC GLUTAMATE RECEPTORS AS POTENTIAL TREATMENTS FOR SCHIZOPHRENIA
por: Conn, P Jeffrey, et al.
Publicado: (2018) -
43.2 MUSCARINIC M1 RECEPTORS: INVOLVEMENT IN THE PATHOPHYSIOLOGY AND TREATMENT OF SCHIZOPHRENIA
por: Dean, Brian, et al.
Publicado: (2018) -
39. VIRUSES AND SCHIZOPHRENIA: IMPLICATIONS FOR PATHOPHYSIOLOGY AND TREATMENT
por: Breier, Alan
Publicado: (2018) -
43.3 COMPLEMENT DYSREGULATION IN SCHIZOPHRENIA: IMPLICATIONS FOR POTENTIAL TREATMENT STRATEGIES
por: Beasley, Clare
Publicado: (2018) -
40. NEW INSIGHTS ON THE ROLE OF NEUROINFLAMMATION IN SCHIZOPHRENIA PATHOPHYSIOLOGY FROM POST MORTEM AND ANIMAL STUDIES
por: Purves-Tyson, Tertia
Publicado: (2018)